{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:34:07Z","timestamp":1776810847016,"version":"3.51.2"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0211973","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T20:40:06Z","timestamp":1549572006000},"page":"e0211973","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Assessing intestinal permeability in Crohn\u2019s disease patients using orally administered 52Cr-EDTA"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2626-3840","authenticated-orcid":true,"given":"Julius Z. H.","family":"von Martels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5754-3821","authenticated-orcid":true,"given":"Arno R.","family":"Bourgonje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermie J. M.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaas Nico","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","article-title":"Intestinal permeability\u2014a new target for disease prevention and therapy","volume":"14","author":"SC Bischoff","year":"2014","journal-title":"BMC Gastroenterology"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ibd.21403","article-title":"Importance of disrupted intestinal barrier in inflammatory bowel diseases","volume":"17","author":"SY Salim","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"ref3","first-page":"872725","article-title":"Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature","volume":"2014","author":"Y Cao","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"H Sokol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gutjnl-2017-314903","article-title":"Adherent-invasive Escherichia coli in inflammatory bowel disease","volume":"67","author":"C Palmela","year":"2018","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.anaerobe.2017.01.001","article-title":"The role of gut microbiota in health and disease: In vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut","volume":"44","author":"JZH von Martels","year":"2017","journal-title":"Anaerobe"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CVI.05517-11","article-title":"Crohn&apos;s disease patients have more IgG-binding fecal bacteria than controls","volume":"19","author":"HJ Harmsen","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3748\/wjg.v20.i5.1165","article-title":"Intestinal barrier in inflammatory bowel disease","volume":"20","author":"L Antoni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.2012.06612.x","article-title":"Abnormal intestinal permeability in Crohn&apos;s disease pathogenesis","volume":"1258","author":"CW Teshima","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/mi.2016.128","article-title":"Gut permeability and mucosal inflammation: bad, good or context dependent","volume":"10","author":"R Ahmad","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1053\/gast.2000.20231","article-title":"Increased intestinal permeability precedes the onset of Crohn&apos;s disease in a subject with familial risk","volume":"119","author":"EJ Irvine","year":"2000","journal-title":"Gastroenterology"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/003655201750153395","article-title":"Is an increased intestinal permeability a valid predictor of relapse in Crohn disease?","volume":"36","author":"J J\u00f8rgensen","year":"2001","journal-title":"Scand J Gastroenterol"},{"issue":"8858","key":"ref13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/0140-6736(93)90882-H","article-title":"Intestinal permeability and the prediction of relapse in Crohn&apos;s disease","volume":"341","author":"J Wyatt","year":"1993","journal-title":"Lancet"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1016\/S0002-9270(99)00500-6","article-title":"Intestinal permeability test as a predictor of clinical course in Crohn&apos;s disease","volume":"94","author":"R D'Inc\u00e0","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1590-8658(01)80045-1","article-title":"Intestinal permeability in Crohn&apos;s disease patients and their first degree relatives","volume":"33","author":"M Secondulfo","year":"2001","journal-title":"Dig Liver Dis"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/gut.44.1.96","article-title":"Different intestinal permeability patterns in relatives and spouses of patients with Crohn&apos;s disease: an inherited defect in mucosal defence?","volume":"44","author":"JD S\u00f6derholm","year":"1999","journal-title":"Gut"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"e0193202","DOI":"10.1371\/journal.pone.0193202","article-title":"Increased fecal calprotectin levels in Crohn\u2019s disease correlate with elevated serum Th1- and Th17-associated cytokines","volume":"13","author":"AR Bourgonje","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ibd.20312","article-title":"Crohn&apos;s disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn&apos;s disease activity index and endoscopic findings","volume":"14","author":"T Sipponen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.47.4.506","article-title":"A simple method for assessing intestinal inflammation in Crohn&apos;s disease","volume":"47","author":"J Tibble","year":"2000","journal-title":"Gut"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","article-title":"Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices","volume":"103","author":"J Langhorst","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1756283X14553384","article-title":"The role and utility of faecal markers in inflammatory bowel disease","volume":"8","author":"FS Lehmann","year":"2015","journal-title":"Therap Adv Gastroenterol"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","article-title":"Biomarkers of Inflammation in Inflammatory Bowel Disease","volume":"149","author":"BE Sands","year":"2015","journal-title":"Gastroenterology"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/003655200750056637","article-title":"Abnormal intestinal permeability predicts relapse in inactive Crohn disease","volume":"35","author":"ID Arnott","year":"2000","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/gut.29.4.511","article-title":"Assessment of the lactulose-mannitol test in Crohn&apos;s disease","volume":"29","author":"F Andre","year":"1988","journal-title":"Gut"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/00365528909089246","article-title":"Schaffalitzky de Muckadell, OB. Intestinal permeability of 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn&apos;s disease and their healthy relatives","volume":"24","author":"M Ainsworth","year":"1989","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00006231-200109000-00009","article-title":"(51)CrEDTA colonic permeability and therapy response in patients with ulcerative colitis","volume":"22","author":"G Arslan","year":"2001","journal-title":"Nucl Med Commun"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0016-5085(83)90317-7","article-title":"Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease","volume":"85","author":"I Bjarnason","year":"1983","journal-title":"Gastroenterology"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/00365529209011181","article-title":"Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change","volume":"27","author":"AP Jenkins","year":"1992","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"ref29","first-page":"151","article-title":"Small bowel and colonic permeability to 51Cr-EDTA in patients with active inflammatory bowel disease","volume":"11","author":"RT Jenkins","year":"1988","journal-title":"Clin Invest Med"},{"issue":"5","key":"ref30","first-page":"430","article-title":"Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease","volume":"108","author":"CA O'Morain","year":"1986","journal-title":"J Lab Clin Med"},{"issue":"10","key":"ref31","first-page":"770","article-title":"Measurement of intestinal permeability using 51Cr-EDTA","volume":"80","author":"Y Peled","year":"1985","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/BF01540405","article-title":"Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn&apos;s disease","volume":"35","author":"L Pironi","year":"1990","journal-title":"Dig Dis Sci"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00005176-198707000-00007","article-title":"Intestinal permeability to [51Cr]EDTA in children with Crohn&apos;s disease and celiac disease","volume":"6","author":"D Turck","year":"1987","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jn\/135.4.837","article-title":"Dietary fructooligosaccharides increase intestinal permeability in rats","volume":"135","author":"SJ Ten Bruggencate","year":"2005","journal-title":"J Nutr"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jn\/136.1.70","article-title":"Dietary fructooligosaccharides affect intestinal barrier function in healthy men","volume":"136","author":"SJ Ten Bruggencate","year":"2006","journal-title":"J Nutr"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.47.4.527","article-title":"COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin","volume":"47","author":"G Sigthorsson","year":"2000","journal-title":"Gut"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/0284185195036S39930","article-title":"Intestinal permeability measurements\u2014a new application for water soluble contrast media?","volume":"399","author":"R Andersen","year":"1995","journal-title":"Acta Radiol Suppl"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3109\/00365529409092484","article-title":"Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease","volume":"29","author":"I Bjarnason","year":"1994","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3109\/00365529509101627","article-title":"Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man","volume":"30","author":"H Oman","year":"1995","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/00365528909093059","article-title":"Cr-ethylenediaminetetraacetic acid absorption test. Methodologic aspects","volume":"24","author":"L. Aabakken","year":"1989","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/cs0710071","article-title":"Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability","volume":"71","author":"DG Maxton","year":"1986","journal-title":"Clin Sci (Lond)"},{"key":"ref42","first-page":"470","article-title":"Soluble Chromium indicator measured by atomic absorption in digestion experiments","volume":"82","author":"W Binnerts","year":"1968","journal-title":"Veterinary Record"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.forsciint.2005.04.020","article-title":"Metal and metalloid multi-elementary ICP-MS validation in whole blood, plasma, urine and hair","volume":"153","author":"J Goull\u00e9","year":"2005","journal-title":"Forensic Sci Int"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1128\/AEM.68.6.2982-2990.2002","article-title":"Extensive Set of 16S rRNA-Based Probes for Detection of Bacteria in Human Feces","volume":"68","author":"HJM Harmsen","year":"2002","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1078\/0723-2020-00015","article-title":"Fusobacterium prausnitzii and Related Species Represent a Dominant Group Within the Human Fecal Flora","volume":"24","author":"A Suau","year":"2001","journal-title":"Syst Appld Microbiol"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1128\/AEM.56.6.1919-1925.1990","article-title":"Combination of 16S rRNA-Targeted Oligonucleotide Probes with Flow Cytometry for Analyzing Mixed Microbial Populations","volume":"56","author":"RI Amann","year":"1990","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1128\/IAI.62.11.5191-5194.1994","article-title":"Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization","volume":"62","author":"LK Poulsen","year":"1994","journal-title":"Infect Immun"},{"key":"ref48","unstructured":"[Anonymous]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.inchem.org\/documents\/ehc\/ehc\/ehc61.htm\" xlink:type=\"simple\">http:\/\/www.inchem.org\/documents\/ehc\/ehc\/ehc61.htm<\/ext-link>."},{"key":"ref49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jim.2014.12.015","article-title":"Methods to determine intestinal permeability and bacterial translocation during liver disease","volume":"421","author":"L Wang","year":"2015","journal-title":"J Immunol Methods"},{"issue":"2","key":"ref50","first-page":"247","article-title":"Can fecal calprotectin better stratify Crohn&apos;s disease activity index?","volume":"28","author":"E Scaioli","year":"2015","journal-title":"Ann Gastroenterol"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1136\/gutjnl-2012-303957","article-title":"Role of endoscopy, cross-sectional imaging and biomarkers in Crohn&apos;s disease monitoring","volume":"62","author":"JM Benitez","year":"2013","journal-title":"Gut"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.cgh.2008.06.010","article-title":"Relationships between disease activity and serum and fecal biomarkers in patients with Crohn&apos;s disease","volume":"6","author":"J Jones","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/003655200750024551","article-title":"Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid","volume":"35","author":"A Berstad","year":"2000","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.MIB.0000168371.87283.4b","article-title":"Hyperresponsiveness of the mucosal barrier in Crohn&apos;s disease is not tumor necrosis factor-dependent","volume":"11","author":"P Suenaert","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"E988","DOI":"10.3390\/nu10080988","article-title":"The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation","volume":"10","author":"K Hiippala","year":"2018","journal-title":"Nutrients"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0016-5085(89)91499-6","article-title":"Intestinal permeability in patients with Crohn&apos;s disease and their healthy relatives","volume":"97","author":"KD Katz","year":"1989","journal-title":"Gastroenterology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/0470090480.ch11","article-title":"Genetic aspects of intestinal permeability in inflammatory bowel disease","volume":"263","author":"K Takeuchi","year":"2004","journal-title":"Novartis Found Symp"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-105-6-883","article-title":"Increased intestinal permeability in patients with Crohn&apos;s disease and their relatives. A possible etiologic factor","volume":"105","author":"D Hollander","year":"1986","journal-title":"Ann Intern Med"},{"issue":"7","key":"ref59","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0016-5085(03)00383-4","article-title":"Subclinical intestinal inflammation: an inherited abnormality in Crohn\u2019s disease relatives?","volume":"124","author":"B Thjodleifsson","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"AD Kostic","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.52.2.237","article-title":"Alterations of the dominant faecal bacterial groups in patients with Crohn&apos;s disease of the colon","volume":"52","author":"P Seksik","year":"2003","journal-title":"Gut"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0211973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T13:29:27Z","timestamp":1694611767000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0211973"}},"subtitle":[],"editor":[{"given":"Jan S.","family":"Suchodolski","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":61,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0211973","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]}}}